Busse C, Mitolo M, Mozzetta S, Venneri A, Cagnin A
Front Psychiatry. 2024; 15:1461620.
PMID: 39720441
PMC: 11666550.
DOI: 10.3389/fpsyt.2024.1461620.
Konishi K, Jacobs E, Aroner S, De Vivo I, Smith B, Scribner-Weiss B
Horm Behav. 2024; 165:105631.
PMID: 39232410
PMC: 11438173.
DOI: 10.1016/j.yhbeh.2024.105631.
Raposo Pereira F, George N, Dalla Barba G, Dubois B, La Corte V
Front Aging Neurosci. 2024; 16:1414419.
PMID: 39175810
PMC: 11340525.
DOI: 10.3389/fnagi.2024.1414419.
Sultana O, Bandaru M, Islam M, Reddy P
Ageing Res Rev. 2024; 100:102414.
PMID: 39002647
PMC: 11384519.
DOI: 10.1016/j.arr.2024.102414.
Manenti R, Baglio F, Pagnoni I, Gobbi E, Campana E, Alaimo C
Front Aging Neurosci. 2024; 16:1414593.
PMID: 38966802
PMC: 11223647.
DOI: 10.3389/fnagi.2024.1414593.
Predictive value for cerebrospinal fluid Alzheimer's disease profile of different measures of verbal episodic memory in patients with MCI.
Salvadori N, Torrigiani E, Paoletti F, Chipi E, Montanucci C, Verderosa C
Sci Rep. 2024; 14(1):12235.
PMID: 38806521
PMC: 11133313.
DOI: 10.1038/s41598-024-62604-z.
Prediction of cognitive decline in healthy aging based on neuropsychiatric symptoms and PET-biomarkers of Alzheimer's disease.
Ronat L, Hanganu A, Chylinski D, Van Egroo M, Narbutas J, Besson G
J Neurol. 2023; 271(4):2067-2077.
PMID: 38114820
DOI: 10.1007/s00415-023-12131-0.
Early Detection of Alzheimer's Disease in Postmenopausal Women Using Thalamic Subnuclear Volumetry.
Kim G, Park K, Jeong G
J Clin Med. 2023; 12(21).
PMID: 37959308
PMC: 10648434.
DOI: 10.3390/jcm12216844.
Biomarkers in Alzheimer's disease: role in early and differential diagnosis and recognition of atypical variants.
Dubois B, von Arnim C, Burnie N, Bozeat S, Cummings J
Alzheimers Res Ther. 2023; 15(1):175.
PMID: 37833762
PMC: 10571241.
DOI: 10.1186/s13195-023-01314-6.
Genuine Memory Deficits as Assessed by the Free and Cued Selective Reminding Test (FCSRT) in the Behavioural Variant of Frontotemporal Dementia. A Systematic Review and Meta-analysis Study.
Macchitella L, Tosi G, Giaquinto F, Iaia M, Rizzi E, Chiarello Y
Neuropsychol Rev. 2023; 34(3):823-837.
PMID: 37736861
PMC: 11473568.
DOI: 10.1007/s11065-023-09613-3.
Differential response to donepezil in MRI subtypes of mild cognitive impairment.
Diaz-Galvan P, Lorenzon G, Mohanty R, Martensson G, Cavedo E, Lista S
Alzheimers Res Ther. 2023; 15(1):117.
PMID: 37353809
PMC: 10288762.
DOI: 10.1186/s13195-023-01253-2.
Memory Outcome in Prodromal and Mild Dementia with Lewy Bodies and Alzheimer's Disease: A Longitudinal Study.
Querry M, Blanc F, Bousiges O, Philippi N, Cretin B, Demuynck C
J Alzheimers Dis. 2023; 94(1):147-162.
PMID: 37212104
PMC: 10357191.
DOI: 10.3233/JAD-221243.
Memory markers in the continuum of the Alzheimer's clinical syndrome.
Parra M, Calia C, Pattan V, Della Sala S
Alzheimers Res Ther. 2022; 14(1):142.
PMID: 36180965
PMC: 9526252.
DOI: 10.1186/s13195-022-01082-9.
Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease.
Benejam B, Aranha M, Videla L, Padilla C, Valldeneu S, Fernandez S
Alzheimers Res Ther. 2022; 14(1):123.
PMID: 36057615
PMC: 9440567.
DOI: 10.1186/s13195-022-01064-x.
Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study.
Grober E, Lipton R, Sperling R, Papp K, Johnson K, Rentz D
Neurology. 2022; 98(13):e1327-e1336.
PMID: 35197359
PMC: 8967421.
DOI: 10.1212/WNL.0000000000200046.
Distinct amyloid and tau PET signatures are associated with diverging clinical and imaging trajectories in patients with amnestic syndrome of the hippocampal type.
Lagarde J, Olivieri P, Tonietto M, Gervais P, Comtat C, Caille F
Transl Psychiatry. 2021; 11(1):498.
PMID: 34588422
PMC: 8481505.
DOI: 10.1038/s41398-021-01628-9.
Decreased Alpha Peak Frequency Is Linked to Episodic Memory Impairment in Pathological Aging.
Puttaert D, Wens V, Fery P, Rovai A, Trotta N, Coquelet N
Front Aging Neurosci. 2021; 13:711375.
PMID: 34475819
PMC: 8406997.
DOI: 10.3389/fnagi.2021.711375.
Story Memory Impairment Rates and Association with Hippocampal Volumes in a Memory Clinic Population.
Wong C, Jeffers S, Bell S, Caldwell J, Banks S, Miller J
J Int Neuropsychol Soc. 2021; 28(6):611-619.
PMID: 34187612
PMC: 8716676.
DOI: 10.1017/S1355617721000850.
VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome.
Lleo A, Carmona-Iragui M, Videla L, Fernandez S, Benejam B, Pegueroles J
Alzheimers Res Ther. 2021; 13(1):119.
PMID: 34183050
PMC: 8240298.
DOI: 10.1186/s13195-021-00861-0.
T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment.
Wearn A, Nurdal V, Saunders-Jennings E, Knight M, Madan C, Fallon S
Neuroimage. 2021; 238:118214.
PMID: 34116150
PMC: 8350145.
DOI: 10.1016/j.neuroimage.2021.118214.